a sympathomimetic amine used as an anorectic agent.
indications It is prescribed to reduce appetite during the first few weeks of dieting during treatment of exogenous obesity. Its beneficial effects slowly disappear over 3 to 12 weeks.
contraindications Cardiovascular disease, hypertension, hyperthyroidism, glaucoma, nervousness, a history of drug abuse, concomitant administration of central nervous system stimulants or monoamine oxidase inhibitors, or known hypersensitivity to this drug prohibits its use.
adverse effects Among the more serious adverse effects are central nervous system stimulation, elevated blood pressure, insomnia, dry mouth, and tolerance to the drug.
BontrilA short-acting central amphetamine-type anorexiant.
Cardiotoxicity—tachycardia, arrhythmias, hypertension, cardiovascular collapse; nervous system—tremor, restlessness, agitation, insomnia, increased motor activity, headache, convulsions, coma, hyperreflexia; rarely, CVA, cerebral vasculitis; high risk of dependency, abuse.